Trevi Therapeutics posted a wider loss in the fourth quarter as it increased spending on trials for chronic cough treatments. The biopharmaceutical company posted a loss of $11.4 million, or 11 cents ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Violin teacher Constance Meyer’s chronic hacking cough was driving other people crazy. The mother of a new student figured out the cause — just in time.

Dr. Duffy says asthma, reflux, post-nasal drip, and drugs like ACE inhibitors for blood pressure, cause the most coughs. GERD, or reflux, can cause coughing, although coughing can also cause GERD.

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...

The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.

Here's what causes bronchitis, how the illness usually spreads and how you can treat symptoms if it affects you or a loved ...

Trevi Therapeutics, Inc. (NASDAQ:TRVI) reported topline results from its Phase 2a RIVER trial of Haduvio (oral nalbuphine ER) ...

In a recent, cross-institutional study, researchers report that healthy human airways are at higher risk for dehydration and ...

Trevi Therapeutics (Nasdaq: TRVI) reported promising results from a mid-stage study of its experimental chronic cough ...

A chronic dry cough is a common symptom of asthma. Inhaled corticosteroids, quick-relief inhalers, and oral medications may help ease asthma symptoms, including a cough. Some alternative ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...